Trial Profile
A retrospective,compassionate access cohort study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Atypical Haemolytic Uraemic Syndrome
- Focus Therapeutic Use
- 28 Sep 2016 New trial record